Merendino Lauren
Insider CIK 1855298 · EPIX Director · MYOV Chief Commercial Officer · DAWN Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 25,816 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 18,978 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 110,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 90,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 90,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 330,200 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 40,565 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 69,375 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer | 2026-04-23 | 2026-04-23 | 60,157 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2026-02-17 | 2026-02-18 | 5,814 | $11.60 | $67.4K | 60,157 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2026-02-15 | 2026-02-18 | 3,688 | — | $0 | 25,816 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2026-02-15 | 2026-02-18 | 3,687 | — | $0 | 40,565 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2026-02-15 | 2026-02-18 | 4,625 | — | $0 | 69,375 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2026-02-15 | 2026-02-18 | 3,162 | — | $0 | 18,978 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2026-02-15 | 2026-02-18 | 3,162 | — | $0 | 53,971 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2026-02-15 | 2026-02-18 | 3,688 | — | $0 | 57,659 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2026-02-15 | 2026-02-18 | 3,687 | — | $0 | 61,346 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2026-02-15 | 2026-02-18 | 4,625 | — | $0 | 65,971 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2026-01-30 | 2026-01-30 | 74,000 | — | $0 | 74,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2026-01-30 | 2026-01-30 | 110,000 | — | $0 | 110,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2025-11-17 | 2025-11-18 | 3,726 | $8.91 | $33.2K | 50,809 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-11-15 | 2025-11-18 | 3,687 | — | $0 | 44,252 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-11-15 | 2025-11-18 | 3,687 | — | $0 | 29,504 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-11-15 | 2025-11-18 | 3,162 | — | $0 | 22,140 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-11-15 | 2025-11-18 | 3,687 | — | $0 | 54,535 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-11-15 | 2025-11-18 | 3,687 | — | $0 | 50,848 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-11-15 | 2025-11-18 | 3,162 | — | $0 | 47,161 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 90,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 90,000 | — | $0 | 90,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 90,000 | — | $0 | 90,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 330,200 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 330,200 | — | $0 | 330,200 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 90,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2025-08-18 | 2025-08-19 | 3,766 | $6.77 | $25.5K | 41,931 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-08-15 | 2025-08-19 | 3,687 | — | $0 | 33,191 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-08-15 | 2025-08-19 | 3,687 | — | $0 | 47,939 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-08-15 | 2025-08-19 | 3,162 | — | $0 | 25,302 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-08-15 | 2025-08-19 | 3,687 | — | $0 | 45,697 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-08-15 | 2025-08-19 | 3,162 | — | $0 | 38,323 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-08-15 | 2025-08-19 | 3,687 | — | $0 | 42,010 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2025-05-16 | 2025-05-19 | 3,927 | $6.26 | $24.6K | 35,161 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-05-15 | 2025-05-19 | 3,162 | — | $0 | 28,464 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-05-15 | 2025-05-19 | 3,687 | — | $0 | 36,878 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2025-05-15 | 2025-05-19 | 3,687 | — | $0 | 51,626 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-05-15 | 2025-05-19 | 3,687 | — | $0 | 35,401 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-05-15 | 2025-05-19 | 3,162 | — | $0 | 31,714 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2025-05-15 | 2025-05-19 | 3,687 | — | $0 | 39,088 | SEC↗ |
| EPIX ESSA Pharma Inc. | A Award deriv | 2024-03-25 | 2024-03-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MYOV Myovant Sciences Ltd. | D To issuer deriv | 2023-03-10 | 2023-03-10 | 103,703 | — | $0 | 0 | SEC↗ |
| MYOV Myovant Sciences Ltd. | D To issuer deriv | 2023-03-10 | 2023-03-10 | 123,300 | — | $0 | 0 | SEC↗ |
| MYOV Myovant Sciences Ltd. | D To issuer | 2023-03-10 | 2023-03-10 | 147,747 | — | $0 | 0 | SEC↗ |
| MYOV Myovant Sciences Ltd. | D To issuer | 2023-03-10 | 2023-03-10 | 21,791 | — | $0 | 147,747 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2023-01-18 | 2023-01-20 | 2,008 | $26.89 | $54.0K | 169,538 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2022-10-18 | 2022-10-20 | 1,703 | $25.20 | $42.9K | 171,546 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2022-07-18 | 2022-07-20 | 1,704 | $12.87 | $21.9K | 173,249 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2022-04-19 | 2022-04-21 | 7,049 | $10.45 | $73.7K | 174,953 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award | 2022-04-15 | 2022-04-19 | 103,703 | — | $0 | 182,002 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award deriv | 2021-04-15 | 2021-04-19 | 123,300 | — | $0 | 123,300 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award | 2021-04-15 | 2021-04-19 | 78,299 | — | $0 | 78,299 | SEC↗ |